InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,681.20
(
-2.17%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.32
(
0.24%
)
Bitcoin
57,218.13
(
-0.23%
)
Post# of 252581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120031
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 52072

Sunday, 09/09/2007 8:27:14 PM

Sunday, September 09, 2007 8:27:14 PM

Post# of 252581
>Maybe I'm more suspicious with Lilly after the Zyprexa case but those points are disturbing.<

The dropout numbers are indeed odd. I wouldn’t be suspicious on account of LLY’s off-label marketing of Zyprexa. However, I might be suspicious inasmuch as LLY absolutely, positively needs a blockbuster encore to Zyprexa or the company’s financials will be in deep doo-doo. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up